Table 1 Baseline characteristics by randomization group variable
Control (n = 46) | Strategy 1 (n = 100) | Strategy 2 (n = 101) | Strategies 1 and 2 (n = 201) | |
---|---|---|---|---|
Age, mean, years (s.d.) | 56.2 (11.4) | 57.0 (10.7) | 55.8 (11.0) | 56.4 (10.9) |
Female, n | 32 (69.6%) | 68 (68.0%) | 71 (70.3%) | 139 (69.2%) |
Race, n | ||||
Black or African American | 6 (13.0%) | 23 (23.0%) | 22 (21.8%) | 45 (22.4%) |
White | 36 (78.3%) | 73 (73.0%) | 72 (71.3%) | 145 (72.1%) |
Married/living with partner, n | 30 (65.2%) | 70 (70.0%) | 60 (59.4%) | 130 (64.7%) |
Employed full-time (≥40 h per week), n | 25 (54.3%) | 60 (60.0%) | 47 (46.5%) | 107 (53.2%) |
Education, n | ||||
Bachelor’s degree | 17 (37.0%) | 36 (36.0%) | 31 (30.7%) | 67 (33.3%) |
Graduate degree | 14 (30.4%) | 27 (27.0%) | 32 (31.7%) | 59 (29.4%) |
Annual household income, n | ||||
<US$35,000 | 1 (2.2%) | 6 (6.0%) | 8 (7.9%) | 14 (7.0%) |
US$35,000 to <US$50,000 | 5 (10.9%) | 8 (8.0%) | 12 (11.9%) | 20 (10.0%) |
US$50,000 to <US$75,000 | 7 (15.2%) | 24 (24.0%) | 17 (16.8%) | 41 (20.4%) |
US$75,000 to <US$100,000 | 16 (34.8%) | 15 (15.0%) | 13 (12.9%) | 28 (13.9%) |
US$100,000 to <US$125,000 | 4 (8.7%) | 10 (10.0%) | 11 (10.9%) | 21 (10.4%) |
≥US$125,000 | 13 (28.3%) | 37 (37.0%) | 40 (39.6%) | 77 (38.3%) |
No children living in the household, n | 35 (76.1%) | 75 (75.0%) | 77 (76.2%) | 152 (75.6%) |
People the participant shops/cooks for at home, including the participant, n | ||||
1 or 2 | 32 (69.6%) | 68 (68.0%) | 71 ((70.3%) | 139 (69.2%) |
≥3 | 14 (30.4%) | 32 (32.0%) | 30 (29.7%) | 62 (30.8%) |
Previous myocardial infarction or stroke, n | 5 (10.9%) | 7 (7.0%) | 5 (5.0%) | 12 (6.0%) |
Treated with hypertension meds, n | 31 (67.4%) | 77 (77.0%) | 73 (72.3%) | 150 (74.6%) |
Blood pressure, mean, mmHg (s.d.) | ||||
Systolic | 130.0 (16.4) | 129.8 (18.6) | 128.4 (14.9) | 129.1 (16.8) |
Diastolic | 85.7 (11.1) | 82.1 (11.6) | 83.4 (10.4) | 82.8 (11.0) |
Body mass index, mean, kg m–2 (s.d.) | 33.8 (7.2) | 34.0 (7.9) | 32.9 (8.1) | 33.5 (8.0) |
Treatment with hypercholesterolemia meds, n | 20 (43.5%) | 47 (47.0%) | 37 (36.6%) | 136 (67.7%) |
Non-HDL-C, mean, mg dl–1 (s.d.) | 107.0 (32.5) | 115.2 (37.0) | 112.5 (35.3) | 113.9 (36.1) |
Total cholesterol, mean, mg dl–1 (s.d.) | 158.5 (40.0) | 167.4 (41.2) | 168.1 (40.7) | 167.8 (40.9) |
TG, mean, mg dl–1 (s.d.) | 170.5 (84.1) | 173.0 (95.3) | 159.2 (96.2) | 166.0 (95.8) |